Journal of Antimicrobial Chemotherapy (1983) 12, 489-496
© 1983 The British Society for Antimicrobial Chemotherapy
research-article |
Subjective response to lysine in the therapy of herpes simplex


*Research Department, General Nutrition Corporation Fargo, North Dakota, U.S.A.
Department of Medicine, Indiana University School of Medicine Indianapolis, Indiana, U.S.A.
Department of Computer Science, University of California at Santa Barbara Santa Barbara, California, U.S.A.
accepted 19 May 1983
Reprint requests to: Dr D. E. Walsh, Research Department, General Nutrition Corporation, P.O. Box 349, Fargo, ND 58107, U.S.A.
To test the effect of lysine supplementation on herpes infection, 1543 subjects were surveyed by questionnaire after a six-month trial period. The study included subjects with cold sores, canker sores, and genital herpes. Of these, 54% had been diagnosed and treated by a physician. The results showed that the average dosage used was 936 mg of lysine daily. Eighty-four per cent of those surveyed said that lysine supplementation prevented recurrence or decreased the frequency of herpes infection. Whereas 79% described their symptoms as severe or intolerable without lysine, only 8% used these terms when taking lysine. Without lysine, 90% indicated that healing took six to 15 days, but with lysine 83% stated that lesions healed in five days or less. Overall, 88% considered supplemental lysine an effective form of treatment for herpes infection.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Kagan Failure of Lysine? Arch Dermatol, January 1, 1985; 121(1): 21 - 21. [Abstract] [PDF] |
||||
